Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
2024;403(10434):e21-e31
Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons
The Rebound-Risk Estimator is a feature the brand describes as an "educational estimate of post-medication rebound risk based on the habits and signals you log." The brand explicitly labels it as "behavioral nudges, not medical advice." Weight regain after GLP-1 discontinuation is a documented concern in published research - a 2025 systematic review and meta-analysis published in eClinicalMedicine confirmed that weight, HbA1c, and blood pressure consistently rebound after cessation
Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients
US$ 23.28
US$ 29.45
US$ 29.56
